Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification

Completed · Not applicable

Conditions studied: Ocular Surface Disease, Glaucoma, Open-Angle

In brief

This prospective interventional single-arm trial evaluates measures changes in ocular surface disease parameters in eyes with mild to moderate open-angle glaucoma (OAG) on 1-4 glaucoma medications who undergo phacoemulsification and trabecular micro-bypass stent(s) implantation (iStent or iStent inject).

Key facts

Study ID
NCT04452279
Run by
Vance Thompson Vision
People needed
47
Starts
2018-05-01
Expected to finish
2019-08-15
Last updated by the study team
2020-06-30

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.